src: "Wir greifen spezifische Ziele an, ohne genau feststellen zu müssen, welche Proteine die T-Zellen erkennen", sagte Dr. Ronald Levy, Onkologie-Professor an der Stanford University School of Medicine und der leitende Autor der Studie "Science Translational Medicine" Aussage.
tgt: "We're attacking specific targets without having to identify exactly what proteins the T cells are recognizing," Dr. Ronald Levy, a professor of oncology at Stanford University School of Medicine and the senior author of the Science Translational Medicine study, said in a statement.